dc.contributor.author | Ozer, Serdar | |
dc.contributor.author | Kocak, Funda | |
dc.contributor.author | Karabay, Oguz | |
dc.contributor.author | Turanli, Munevver | |
dc.contributor.author | Mert, Ali | |
dc.contributor.author | Batirel, Ayse | |
dc.contributor.author | GÜÇLÜ, ERTUĞRUL | |
dc.contributor.author | Arslan, Ferhat | |
dc.date.accessioned | 2021-03-03T10:51:54Z | |
dc.date.available | 2021-03-03T10:51:54Z | |
dc.identifier.citation | Batirel A., GÜÇLÜ E., Arslan F., Kocak F., Karabay O., Ozer S., Turanli M., Mert A., "Comparable efficacy of tenofovir versus entecavir and predictors of response in treatment-naive patients with chronic hepatitis B: a multicenter real-life study", INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, cilt.28, ss.153-159, 2014 | |
dc.identifier.issn | 1201-9712 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_250b2f37-1829-4929-96e2-f2165ac6029f | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/29786 | |
dc.identifier.uri | https://doi.org/10.1016/j.ijid.2014.09.004 | |
dc.description.abstract | Objective: To compare responses to tenofovir (TDF) and entecavir (ETV) therapy. | |
dc.language.iso | eng | |
dc.subject | İmmünoloji | |
dc.subject | Temel Bilimler | |
dc.subject | BULAŞICI HASTALIKLAR | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.title | Comparable efficacy of tenofovir versus entecavir and predictors of response in treatment-naive patients with chronic hepatitis B: a multicenter real-life study | |
dc.type | Makale | |
dc.relation.journal | INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | |
dc.contributor.department | Istanbul Kartal Dr Lutfi Kirdar Training & Research Hospital , , | |
dc.identifier.volume | 28 | |
dc.identifier.startpage | 153 | |
dc.identifier.endpage | 159 | |
dc.contributor.firstauthorID | 218124 | |